Abstract
Twenty-nine DS adults with behavioral disorders. The patients were managed with psychoprophylaxis followed by oral CS using 15 or 30mg midazolam. Vital parameters were monitored. The Houpt and Brietkopf and Buttner scales were used. Patients under CS received an initial dose of 15mg midazolam; however, 51.72% needed a 30mg dose at the following sessions. Results showed that 71.4% treated with the 15mg dose had Houpt scale overall behavior scores of 4 or 5, while 93.33% of those receiving 30mg had scores of 5 or 6 (chi-square=15.95 p<.01). Psychoprophylaxis sessions followed by CS procedures using oral midazolam in adult DS with behavioral disorders were shown to be a useful strategy to perform routine dental treatment safely. Midazolam produces anterograde amnesia, and participants were more cooperative in the following visits.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
